171 related articles for article (PubMed ID: 15733059)
1. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.
Guo YL; Colman RW
J Thromb Haemost; 2005 Apr; 3(4):670-6. PubMed ID: 15733059
[TBL] [Abstract][Full Text] [Related]
2. Kininostatin as an antiangiogenic inhibitor: what we know and what we do not know.
Guo YL; Wang S; Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1931-40. PubMed ID: 12489806
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen.
Colman RW; Pixley RA; Sainz IM; Song JS; Isordia-Salas I; Muhamed SN; Powell JA; Mousa SA
J Thromb Haemost; 2003 Jan; 1(1):164-70. PubMed ID: 12871554
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen.
Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1887-94. PubMed ID: 12489802
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.
Sun D; McCrae KR
Blood; 2006 Jun; 107(12):4714-20. PubMed ID: 16418331
[TBL] [Abstract][Full Text] [Related]
7. Regulation of angiogenesis by the kallikrein-kinin system.
Colman RW
Curr Pharm Des; 2006; 12(21):2599-607. PubMed ID: 16842160
[TBL] [Abstract][Full Text] [Related]
8. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
10. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
[TBL] [Abstract][Full Text] [Related]
11. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
12. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
[TBL] [Abstract][Full Text] [Related]
13. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA
Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460
[TBL] [Abstract][Full Text] [Related]
14. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
15. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5.
Zhang JC; Claffey K; Sakthivel R; Darzynkiewicz Z; Shaw DE; Leal J; Wang YC; Lu FM; McCrae KR
FASEB J; 2000 Dec; 14(15):2589-600. PubMed ID: 11099478
[TBL] [Abstract][Full Text] [Related]
16. Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein.
Mashiko H; Miyamoto K; Takahashi H
Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):647-56. PubMed ID: 9854812
[TBL] [Abstract][Full Text] [Related]
17. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
18. Human plasma kallikrein-kinin system: physiological and biochemical parameters.
Bryant JW; Shariat-Madar Z
Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):234-50. PubMed ID: 19689262
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.
Liu Y; Sainz IM; Wu Y; Pixley R; Espinola RG; Hassan S; Khan MM; Colman RW
Exp Cell Res; 2008 Feb; 314(4):774-88. PubMed ID: 18062965
[TBL] [Abstract][Full Text] [Related]
20. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
